Tandem Diabetes Care (NSDQ:TNDM) today priced an underwritten public offering of 4,630,000 shares of its common stock, Series A warrants and Series B warrants to buy 4,630,000 shares of common stock at $3.50 apiece.
The San Diego, Calif.-based company said it expects to bring in $16.2 million in gross proceeds from the offering.
Get the full story at our sister site, Drug Delivery Business News.
The post Tandem prices $16m public offering appeared first on MassDevice.